Tuesday, October 15, 2019

Thermo Fisher Scientific Opens New Bioprocess Design Center in Shanghai

Facility enables customer collaboration to optimize bioprocessing solutions Thermo Fisher Scientific, the world leader in serving science, today opened its first Bioprocess Design Center in Shanghai, China. The new center is part of a strategy to...

Sutter Health Collaborates with Qventus to Drive Down Pharmaceutical Costs

The not-for-profit Sutter Health network announced today that it will collaborate with Qventus to use the company's artificial intelligence (AI) platform to enhance inpatient pharmacy operations across its healthcare system. The real-time platform...

Mylan Launches First AP-rated Generic Avelox® Injection

Mylan N.V. today announced the U.S. launch of Moxifloxacin Hydrochloride in 0.8% Sodium Chloride Injection, 400 mg/250 mL (1.6 mg/mL) in 250 mL single-dose flexible bags, the first AP-rated generic version of Bayer's...

Pharmaceutical Industry Study Focuses on Using Medical Affairs to Improve Payer Interactions

In the wake of the rising influence of public and private payers, pharmaceutical companies are seeking more effective ways to work with payer organizations. In particular, pharma is turning to the medical affairs function to...

FDA approves Mylotarg for treatment of acute myeloid leukemia

The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also...

Enhanced Healthcare Partners Announces Investment in SCA Pharmaceuticals

Enhanced Healthcare Partners ("EHP"), a private equity firm focused exclusively on investing in the healthcare industry, has announced its investment in SCA Pharmaceuticals ("SCA"), a sterile compounding leader specializing in preparing sterile pharmaceuticals...

Revolutionary Erectile Dysfunction Treatment, GAINSWave®, Now Offered by Havkin Urology in Florida

Havkin Urology is implementing a non-invasive and drug free solution for Erectile Dysfunction (ED) called GAINSWave, which boasts a 75% success rate. GAINSWave is a premium brand of shockwave therapy designed to remove micro-plaque and stimulate...

Alzheimer’s Disease: Cannabis Formulation Shows Promise

Known as America's most expensive disease, with an estimated cost to the U.S. economy of 6 billion in 2016, Alzheimer's disease (AD) affects more than 5.3 million Americans. Over the next 20 years, the number of...

Mitra Biotech Partners with Gotect Diagnostic in Israel

Mitra Biotech, a global leader in advancing the personalization of cancer treatment, today announced an agreement with Gotect Diagnostic for the exclusive right to represent Mitra in Israel. Mitra's CANscript™ platform recreates a patient's own...

New Models and Approaches to Condition Management Leading to Accelerated Growth of Solutions

New Chilmark Research report assesses maturity of solution features, sets forth rationale for rapid growth. Key healthcare stakeholders are accelerating the adoption of more personalized and holistic approaches to chronic condition management, driven by...

Connect with us

4,472FansLike
1,007FollowersFollow
12,053FollowersFollow

Popular Posts